Systemic Diseases and Chronic Rhinosinusitis

  • Christine Reger
  • Christina F. Herrera
  • Megan Abbott
  • Alexander G. Chiu


Human Immunodeficiency Virus Systemic Lupus Erythematosus Cystic Fibrosis Cystic Fibrosis Patient Nasal Mucosa 


  1. 1.
    Tami TA. Granulomatous diseases and chronic rhinosinusitis. Otolaryngol Clin N Am 2005;38:1267–1278.CrossRefGoogle Scholar
  2. 2.
    Lloyd G, Lund VJ, Beale T, et al. Radiology in focus: rhinologic changes in Wegener’s granulomatosis. J Laryngol Otol 2002;116: 565–569.PubMedGoogle Scholar
  3. 3.
    Woywodt A, Haubitz M, Haller H, et al. Wegener’s granulomatosis. Lancet 2006;367: 1362–1366.PubMedCrossRefGoogle Scholar
  4. 4.
    Lagnese ME, Dhaliwal G. Case report: an initial diagnosis of Wegener’s granulomatosis in an 82-year-old woman. Hosp Phys 2007;52:33–36.Google Scholar
  5. 5.
    Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 1990;33:1101–1107.PubMedCrossRefGoogle Scholar
  6. 6.
    Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;337:1124–1234.CrossRefGoogle Scholar
  7. 7.
    Cox CE, Davis-Allen A, Judson MA. Sarcoidosis. Med Clin N Am 2005;89:817–828.PubMedCrossRefGoogle Scholar
  8. 8.
    Wang X, Kim J, McWilliams R, Cutting G. Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation. Arch Otolaryngol Head Neck Surg 2005;131:237–240.PubMedCrossRefGoogle Scholar
  9. 9.
    Gilljam M, Ellis L, Corey M, Zielenski J, Durie P, Tullis E. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest 2004;126:1215–1224.PubMedCrossRefGoogle Scholar
  10. 10.
    Jorissen M, De Boek K, Cuppens H. Genotype-phenotype correlations for the paranasal sinuses in cystic fibrosis. Am J Respir Crit Care Med 1999;159:1412–1416.PubMedGoogle Scholar
  11. 11.
    Young M, Gould J, Upton, G. Nasal polyposis in children with cystic fibrosis: a long-term follow-up study. Ann Otol Rhinol Laryngol 2002;111:1081–1086.Google Scholar
  12. 12.
    Rosenstein B, Cutting G. The diagnosis of cystic fibrosis: a consensus statement. J Pediatr 1998;132:589–595.PubMedCrossRefGoogle Scholar
  13. 13.
    Ratgen F, Doring G. Seminar: cystic fibrosis. Lancet 2003;361:681–689.CrossRefGoogle Scholar
  14. 14.
    Flume P, O’Sullivan B, Robinson K, et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007;176:957–969.PubMedCrossRefGoogle Scholar
  15. 15.
    Abril A, Calamia KT, Cohen MD. The Churg Strauss syndrome (allergic granulomatous angiitis): review and update. Semin Arthritis Rheum 2003;33:106–114.PubMedCrossRefGoogle Scholar
  16. 16.
    Pagnoux C, Gulpain P, Guillevin L. Churg-Strauss syndrome. Curr Opin Rheumatol 2007;19:25–32.PubMedCrossRefGoogle Scholar
  17. 17.
    Keogh KA, Specks U. Churg-Strauss syndrome. Semin Respir Crit Care Med 2006;27: 148–157.PubMedCrossRefGoogle Scholar
  18. 18.
    Rapini RP, Warner NB. Relapsing polychondritis. Clinics Dermatol 2006;24:482–485.CrossRefGoogle Scholar
  19. 19.
    Liu CM, Hata TR, Swinyer L, et al. Morphology: relapsing polychondritis. Int J Dermatol 2003;42:707–708.PubMedCrossRefGoogle Scholar
  20. 20.
    Kent PD, Michet CJ, Luthra HS, et al. Relapsing polychondritis. Curr Opin Rheumatol 2004;16:56–61.PubMedCrossRefGoogle Scholar
  21. 21.
    D’Cruz DP, Khamashta MA, Hughes GRV. Systemic lupus erythematosis. Lancet 2007;369:587–596.PubMedCrossRefGoogle Scholar
  22. 22.
    Rothfield N, Sontheimer R, Bernstein M. Lupus erythematosis: systemic and cutaneous manifestations. Clinics Dermatol 2006;24:348–362.CrossRefGoogle Scholar
  23. 23.
    Gungor A, Adusumilli V, Corey J. Fungal sinusitis: progression of disease in immunosuppression. Ear Nose Throat J 1998;77:207–212.PubMedGoogle Scholar
  24. 24.
    Mandava P, Chaljub G, Patterson K, et al. MR imaging of cavernous sinus invasion by mucormycosis: a case study. Clin Neurol Neurosurg 2001;103:101–104.PubMedCrossRefGoogle Scholar
  25. 25.
    Mylona S, Tzavara V, Ntai S, et al. Chronic invasive sinus aspergillosis in an immunocompetent patient: a case report. Dentomaxillofacial Radiol 2007;36:102–104.Google Scholar
  26. 26.
    Kauffman CA. Fungal infections. Proc Am Thorac Soc (PATS) 2006;3:35–40.CrossRefGoogle Scholar
  27. 27.
    Iwen PC, Rupp ME, Hinrichs SH. Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature. Clin Infect Dis 1997;24:1178–1184.PubMedCrossRefGoogle Scholar
  28. 28.
    Goh BT. Syphilis in adults. Sex Transm Dis 2005;81:448–452.Google Scholar
  29. 29.
    Baughn RE, Musher DM. Secondary syphilitic lesions. Clin Microbiol Rev 2005;18: 205–216.PubMedCrossRefGoogle Scholar
  30. 30.
    Hamlyn E, Marriott D, Gallagher RM. Secondary syphilis presenting as tonsillitis in three patients. J Laryngol Otol 2006;120:602–604.PubMedCrossRefGoogle Scholar
  31. 31.
    Wallace RJ, Brown-Elliott BA, Hall L, et al. Clinical and laboratory features of Mycobacterium mageritense. J Clin Microbiol 2002;40:2930–2935.PubMedCrossRefGoogle Scholar
  32. 32.
    Cincik H, Ferguson BJ. The impact of endoscopic cultures on care in rhinosinusitis. Layngoscope 2006;116:1562–1568.CrossRefGoogle Scholar
  33. 33.
    Griffith DE. Therapy of nontuberculous mycobacterial disease. Curr Opin Infect Dis 2007;20:198–203.PubMedCrossRefGoogle Scholar
  34. 34.
    Hart CA, Rao SK. Rhinoscleroma. J Med Microbiol 2000;49:395–396.PubMedGoogle Scholar
  35. 35.
    Yilmaz M, Aydil U, Vural C, et al. Simultaneous occurrence of nasal and cervical rhinoscleroma. J Otolaryngol 2006;35:206–208.PubMedGoogle Scholar
  36. 36.
    Chain JR, Kingdom TT. Non-Hodgkin’s lymphoma of the frontal sinus presenting as osteomyelitis. Am J Otolaryngol 2006;28:42–45.CrossRefGoogle Scholar
  37. 37.
    Thompson LD. Mini-symposium: head and neck pathology—sinonasal carcinomas. Curr Diagn Pathol 2006;12:40–53.CrossRefGoogle Scholar
  38. 38.
    Al-Hakeem DA, Fedele S, Carlos R, et al. Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol 2007;43:4–14.PubMedCrossRefGoogle Scholar
  39. 39.
    Chen S, Wu CS, Chan K, et al. Primary sinonasal non-Hodgkin’s lymphoma masquerading as chronic rhinosinusitis: an issue of routine histopathological examination. J Laryngol Otol 2003;117:404–407.PubMedCrossRefGoogle Scholar
  40. 40.
    Sabbà C. A rare and misdiagnosed bleeding disorder: hereditary hemorrhagic telangiectasia. J Thromb Haemost 2005;3:2201–2210.PubMedCrossRefGoogle Scholar
  41. 41.
    Kühnel TS, Wagner BH, Schurr CP, et al. Clinical strategy in hereditary hemorrhagic telangiectasia. Am J Rhinol 2005;19:508–513.PubMedGoogle Scholar
  42. 42.
    Geisthoff UW, Sittel C, Plinkert PK. Contact endoscopic findings in hereditary hemorrhagic telangiectasia. Head Neck 2005;28:56–63.CrossRefGoogle Scholar
  43. 43.
    HHT Foundation International. Hereditary Hemorrhagic Telangiectasia page. Available at: Accessed July 12, 2007.
  44. 44.
    Prasad HK, Bhojwani KM, Shnoy V. HIV manifestations in otolaryngology. Am J Otolaryngol 2006;27:179–185.PubMedCrossRefGoogle Scholar
  45. 45.
    Milgrim LM, Rubin JS, Small CB. Mucociliary clearance abnormalities in the HIV-infected patient: a precursor to acute sinusitis. Larnygoscope 1995;105:1202–1208.CrossRefGoogle Scholar
  46. 46.
    Godofsky EW, Zinreich J, Armstrong M, et al. Sinusitis in HIV-infected patients: a clinical and radiographic review. Am J Med 1992;93:163–170.PubMedCrossRefGoogle Scholar
  47. 47.
    Centers for Disease Control. Revised Recommendations for HIV testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings page. Available at: mmwr/preview/mmwrhtml/rr5514a1.htm. Accessed July 12, 2007.
  48. 48.
    Yeni PG, Hammer SM, Hirsch MS, et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA panel. JAMA 2004;292:251–265.PubMedCrossRefGoogle Scholar
  49. 49.
    Wawrose SF, Tami TA, Amoits CP. The role of guaifenesin in the treatment of sinonasal disease in patients infected with the human immunodeficiency virus. Laryngoscope 1992;102:1225–1228.PubMedCrossRefGoogle Scholar
  50. 50.
    Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope 2000;110:1189–1193.PubMedCrossRefGoogle Scholar
  51. 51.
    Shafinoori S, Ginocchio CC, Greenberg AJ, et al. Impact of pneumococcal conjugate vaccine and the severity of winter influenza-like illnesses on invasive pneumococcal infections in children and adults. Pediatr Infect Dis J 2005;24:10–16.PubMedCrossRefGoogle Scholar
  52. 52.
    Talbott JF, Gorti GK, Koch RJ. Midfacial osteomyelitis in a chronic abuser: a case report. Ear Nose Throat J 2001; 80:738–743.Google Scholar
  53. 53.
    Neugebauer P, Fricke J, Neugebauer A, et al. Sinuorbital complications after intranasal cocaine abuse. Strabismus 2004;12:205–209.PubMedCrossRefGoogle Scholar
  54. 54.
    Leibovitch I, Khoramian D, Goldberg RA. Severe destructive sinusitis and orbital apex syndrome as a complication of intranasal cocaine abuse. Am J Emerg Med 2006;24:499–501.PubMedCrossRefGoogle Scholar
  55. 55.
    Gordon RJ, Lowy FD. Bacterial infection in drug users. N Engl J Med 2005;353:1945–1954.PubMedCrossRefGoogle Scholar
  56. 56.
    Klutmans J, van Belkum A, Verburgh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505–520.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Christine Reger
  • Christina F. Herrera
  • Megan Abbott
  • Alexander G. Chiu
    • 1
  1. 1.Department of OtorhinolaryngologyUniversity of PennsylvaniaPhiladelphiaUSA

Personalised recommendations